Development of Value Added Products from Seaweed for Animal Feed and Human Nutraceutical Markets

Tuesday 25 January 2022

BioAtlantis’ Capital Investment for the Development of Value Added Products from Seaweed Extract for Animal Feed and Human Nutraceutical Markets project was part funded by the Irish Government and the European Maritime and Fisheries Fund under the Seafood Capital Investment Scheme and was administered by Bord Iascaigh Mhara (BIM), Ireland’s Seafood Development Agency.”


“This aid allowed us to expedite our plant commissioning and improved our production capacity” John T. O’Sullivan CEO BioAtlantis Ltd.


BioAtlantis provides sustainable technologies to enhance plant, animal and human health. It leads the scientific-based movement to reduce the world’s dependence on agrochemicals and avoid the overuse of antibiotics in animals which is leading to the development of human pathogens resistant to antibiotics.